Burden-of-illness studies

Increasing demand for data on the economic burden of diseases has fostered growing interest in cost-of-illness studies. PAI pioneered the development of techniques of cost-of-illness ascertainment almost 20 years ago. In the 1970s, under contract to the U.S. National Center for Health Statistics, researchers at PAI developed the techniques for incidence-based cost-of-illness studies that remain in use today. Since then, PAI has conducted numerous cost-of-illness studies, including analyses of the costs of coronary heart disease, breast cancer, leukemia, stroke, diabetes, lung cancer, chronic obstructive pulmonary disease, hypercholesterolemia, benign prostatic hypertrophy, and rheumatoid arthritis.